Company
United StatesPublic company, OTC: ENDVEndonovo Therapeutics, Inc. (OTC: ENDV), Woodland Hills, CA – FDA Inspections
Inspection records and compliance data for Endonovo Therapeutics, Inc. in Woodland Hills, California. 3 FDA inspections on record, 1 Form 483, last inspected October 31, 2025. Publicly traded as OTC: ENDV.
Company Profile
This profile covers Endonovo Therapeutics, Inc. based in Woodland Hills, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 1
- Warning letters
- 0
First inspected May 14, 2019. Last inspected October 31, 2025.
Most cited issue areas
- Lack of or inadequate complaint procedures1 inspection
- Quality System Procedures1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 31, 2025 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Medical Devices | 1289500 |
| October 13, 2022 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1181508 |
| May 14, 2019 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1093798 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Endonovo Therapeutics, Inc.
Stock ticker
ENDV
Exchange
OTC
Price as of
November 13, 2026
FEI Number
3014308816
Address
6320 Canoga Ave Fl 15, Woodland Hills, California 91367, United States
Country
United States
ID: 819d1466-398f-4ac9-87a8-052819520724